The pioneering Follistatin gene therapy aims to improve muscle and strength while potentially slowing the aging process.

The therapy uses a circular loop of DNA called a plasmid, designed for easy subcutaneous injection and manufacturing.

Early recipients of this therapy have reportedly experienced significant muscle mass increases, epigenetic age reduction, and telomere lengthening.

The MiniCircle gene therapy has a built-in safety feature where it can be instantly deactivated by taking the antibiotic tetracycline.

This specific experimental gene therapy procedure costs approximately $20,000.

The speaker traveled to Próspera in Honduras, a special zone with its own laws, to receive a gene therapy not approved in the U.S.